<DOC>
	<DOC>NCT01753440</DOC>
	<brief_summary>The aim of the present study is to investigate safety and efficacy of intramyocardial implantation of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy at the time of coronary artery bypass grafting.</brief_summary>
	<brief_title>Allogeneic Stem Cells Implantation Combined With Coronary Bypass Grafting in Patients With Ischemic Cardiomyopathy</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>Age from 18 to 75 years Severe coronary artery disease amenable to surgical revascularization according to current guidelines History of acute myocardial infarction at least 14 days previously Left ventricular ejection fraction (LVEF) â‰¤ 40% as assessed with echocardiography Distinct area of dyskinetic or akinetic left ventricular myocardium corresponding with the infarct localization Patient's informed consent obtained Emergency operation Debilitating chronic disease (eg. malignancy or terminal renal failure) Concomitant valve surgery Previous cardiac surgery Malignant ventricular arrhythmias Haematologic disease Woman in reproductive age Severe psychiatric illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>heart failure</keyword>
	<keyword>stem cells implantation</keyword>
</DOC>